A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)

M. Hidalgo; R. Epelbaum; B. M. Wolpin; S. M. Stemmer; R. Geva; T. Golan; E. Borazanci; M. Borad; K. S. Pedersen; J. O. Park; R. Ramirez; A. Peled; T. M. Lustig; O. Bohana Kashtan; O. Rosenfeld; E. Sorani; K. Schlienger; A. Vainstein Haras; D. D. Von Hoff

doi:10.1093/annonc/mdy288.006

A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)

M. Hidalgo, R. Epelbaum, B. M. Wolpin, S. M. Stemmer, R. Geva, T. Golan, E. Borazanci, M. Borad, K. S. Pedersen, J. O. Park, R. Ramirez, A. Peled, T. M. Lustig, O. Bohana Kashtan, O. Rosenfeld, E. Sorani, K. Schlienger, A. Vainstein Haras, D. D. Von Hoff

Hematology/Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii402
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy288.006
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy288.006

Cite this

Hidalgo, M., Epelbaum, R., Wolpin, B. M., Stemmer, S. M., Geva, R., Golan, T., Borazanci, E., Borad, M., Pedersen, K. S., Park, J. O., Ramirez, R., Peled, A., Lustig, T. M., Bohana Kashtan, O., Rosenfeld, O., Sorani, E., Schlienger, K., Vainstein Haras, A., & Von Hoff, D. D. (2018). A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii402. https://doi.org/10.1093/annonc/mdy288.006

A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC). / Hidalgo, M.; Epelbaum, R.; Wolpin, B. M. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii402.

Research output: Contribution to journal › Article › peer-review

Hidalgo, M, Epelbaum, R, Wolpin, BM, Stemmer, SM, Geva, R, Golan, T, Borazanci, E, Borad, M, Pedersen, KS, Park, JO, Ramirez, R, Peled, A, Lustig, TM, Bohana Kashtan, O, Rosenfeld, O, Sorani, E, Schlienger, K, Vainstein Haras, A & Von Hoff, DD 2018, 'A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii402. https://doi.org/10.1093/annonc/mdy288.006

@article{9aa052ee02764c96a47a663e624102c4,

title = "A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)",

author = "M. Hidalgo and R. Epelbaum and Wolpin, {B. M.} and Stemmer, {S. M.} and R. Geva and T. Golan and E. Borazanci and M. Borad and Pedersen, {K. S.} and Park, {J. O.} and R. Ramirez and A. Peled and Lustig, {T. M.} and {Bohana Kashtan}, O. and O. Rosenfeld and E. Sorani and K. Schlienger and {Vainstein Haras}, A. and {Von Hoff}, {D. D.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy288.006",

language = "English (US)",

volume = "29",

pages = "viii402",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)

AU - Hidalgo, M.

AU - Epelbaum, R.

AU - Wolpin, B. M.

AU - Stemmer, S. M.

AU - Geva, R.

AU - Golan, T.

AU - Borazanci, E.

AU - Borad, M.

AU - Pedersen, K. S.

AU - Park, J. O.

AU - Ramirez, R.

AU - Peled, A.

AU - Lustig, T. M.

AU - Bohana Kashtan, O.

AU - Rosenfeld, O.

AU - Sorani, E.

AU - Schlienger, K.

AU - Vainstein Haras, A.

AU - Von Hoff, D. D.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85064848266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064848266&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy288.006

DO - 10.1093/annonc/mdy288.006

M3 - Article

C2 - 32137008

SN - 0923-7534

VL - 29

SP - viii402

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this